Download PDF
Semin Reprod Med 2021; 39(01/02): 013-023
DOI: 10.1055/s-0041-1730908
Review Article

Immunological Testing in Assisted Reproductive Technology

Joshua Odendaal
1   Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, United Kingdom
2   Tommy's National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
,
Siobhan Quenby
1   Division of Biomedical Sciences, Clinical Sciences Research Laboratories, Warwick Medical School, University of Warwick, Coventry, United Kingdom
2   Tommy's National Centre for Miscarriage Research, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Fetal implantation requires carefully orchestrated involvement of the maternal immune system. Aberrant function within implantation has been suggested as a cause of implantation failure. The emergence of immunological theories of miscarriage has led to immunological testing as an adjuvant treatment in assisted reproductive technology; however, it remains controversial, with mixed evidence both for immunological cause and the benefits of immunological testing. Literature on common methods of immunological testing within assisted reproductive technology is reviewed including those of peripheral and uterine natural killer cells, chronic endometritis, and T-helper cells cytokine ratio. There is little consensus in the evidence on immunological testing in the context of recurrent implantation failure. The field is limited by a lack of uniformity in approach to testing and heterogeneity of the pathophysiological cause. Nevertheless, the maternal immune system is heavily involved in implantation and the new era of personalized medicine ensures that a more defined approach to immunological testing will be achieved.

Keywords

assisted reproductive technology - recurrent implantation failure - immunological testing - natural killer cells - chronic endometritis


Publication History

Article published online:
23 June 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol 2006; 6 (08) 584-594
    CrossrefPubMedGoogle Scholar
  • 2 Bashiri A, Halper KI, Orvieto R. Recurrent implantation failure-update overview on etiology, diagnosis, treatment and future directions. Reprod Biol Endocrinol 2018; 16 (01) 121
    CrossrefPubMedGoogle Scholar
  • 3 Human Fertilisation and Embryology Authority. Treatment Add-ons. Accessed March 13, 2019 at: https://www.hfea.gov.uk/treatments/explore-all-treatments/treatment-add-ons/
    Google Scholar
  • 4 Practice Committee of the American Society for Reproductive Medicine. Electronic address: ASRM@asrm.org, Practice Committee of the American Society for Reproductive Medicine. The role of immunotherapy in in vitro fertilization: a guideline. Fertil Steril 2018; 110 (03) 387-400
    CrossrefPubMedGoogle Scholar
  • 5 Herberman RB, Nunn ME, Holden HT, Lavrin DH. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells. Int J Cancer 1975; 16 (02) 230-239
    CrossrefPubMedGoogle Scholar
  • 6 Caligiuri MA. Human natural killer cells. Blood 2008; 112 (03) 461-469
    CrossrefPubMedGoogle Scholar
  • 7 Moffett A, Shreeve N. First do no harm: uterine natural killer (NK) cells in assisted reproduction. Hum Reprod 2015; 30 (07) 1519-1525
    CrossrefPubMedGoogle Scholar
  • 8 Koopman LA, Kopcow HD, Rybalov B. et al. Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential. J Exp Med 2003; 198 (08) 1201-1212
    CrossrefPubMedGoogle Scholar
  • 9 King A, Birkby C, Loke YW. Early human decidual cells exhibit NK activity against the K562 cell line but not against first trimester trophoblast. Cell Immunol 1989; 118 (02) 337-344
    CrossrefPubMedGoogle Scholar
  • 10 Manaster I, Mandelboim O. The unique properties of uterine NK cells. Am J Reprod Immunol 2010; 63 (06) 434-444
    CrossrefPubMedGoogle Scholar
  • 11 Crespo ÂC, Mulik S, Dotiwala F. et al. Decidual NK cells transfer granulysin to selectively kill bacteria in trophoblasts. Cell 2020; 182 (05) 1125-1139.e18
    CrossrefPubMedGoogle Scholar
  • 12 Hanna J, Wald O, Goldman-Wohl D. et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16− human natural killer cells. Blood 2003; 102 (05) 1569-1577
    CrossrefPubMedGoogle Scholar
  • 13 Arck PC, Hecher K. Fetomaternal immune cross-talk and its consequences for maternal and offspring's health. Nat Med 2013; 19 (05) 548-556
    CrossrefPubMedGoogle Scholar
  • 14 Vacca P, Vitale C, Montaldo E. et al. CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells. Proc Natl Acad Sci U S A 2011; 108 (06) 2402-2407
    CrossrefPubMedGoogle Scholar
  • 15 Male V, Hughes T, McClory S, Colucci F, Caligiuri MA, Moffett A. Immature NK cells, capable of producing IL-22, are present in human uterine mucosa. J Immunol 2010; 185 (07) 3913-3918
    CrossrefPubMedGoogle Scholar
  • 16 Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum Reprod 1991; 6 (06) 791-798
    CrossrefPubMedGoogle Scholar
  • 17 Alecsandru D, García-Velasco JA. Why natural killer cells are not enough: a further understanding of killer immunoglobulin-like receptor and human leukocyte antigen. Fertil Steril 2017; 107 (06) 1273-1278
    CrossrefPubMedGoogle Scholar
  • 18 Xiong S, Sharkey AM, Kennedy PR. et al. Maternal uterine NK cell-activating receptor KIR2DS1 enhances placentation. J Clin Invest 2013; 123 (10) 4264-4272
    CrossrefPubMedGoogle Scholar
  • 19 Moffett A, Colucci F. Co-evolution of NK receptors and HLA ligands in humans is driven by reproduction. Immunol Rev 2015; 267 (01) 283-297
    CrossrefPubMedGoogle Scholar
  • 20 Colucci F. The role of KIR and HLA interactions in pregnancy complications. Immunogenetics 2017; 69 (8-9): 557-565
    CrossrefPubMedGoogle Scholar
  • 21 Díaz-Peña R, de Los Santos MJ, Lucia A, Castro-Santos P. Understanding the role of killer cell immunoglobulin-like receptors in pregnancy complications. J Assist Reprod Genet 2019; 36 (05) 827-835
    CrossrefPubMedGoogle Scholar
  • 22 Hazan AD, Smith SD, Jones RL, Whittle W, Lye SJ, Dunk CE. Vascular-leukocyte interactions: mechanisms of human decidual spiral artery remodeling in vitro. Am J Pathol 2010; 177 (02) 1017-1030
    CrossrefPubMedGoogle Scholar
  • 23 King A, Gardner L, Loke YW. Evaluation of oestrogen and progesterone receptor expression in uterine mucosal lymphocytes. Hum Reprod 1996; 11 (05) 1079-1082
    CrossrefPubMedGoogle Scholar
  • 24 Chong HP, Quenby SM. Natural killer cells and reproductive health. Obstet Gynaecol 2016; 18: 91-97
    CrossrefPubMedGoogle Scholar
  • 25 Guo W, Li P, Zhao G, Fan H, Hu Y, Hou Y. Glucocorticoid receptor mediates the effect of progesterone on uterine natural killer cells. Am J Reprod Immunol 2012; 67 (06) 463-473
    CrossrefPubMedGoogle Scholar
  • 26 Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002; 2 (09) 656-663
    CrossrefPubMedGoogle Scholar
  • 27 Zhang J, Chen Z, Smith GN, Croy BA. Natural killer cell-triggered vascular transformation: maternal care before birth?. Cell Mol Immunol 2011; 8 (01) 1-11
    CrossrefPubMedGoogle Scholar
  • 28 Lash GE, Schiessl B, Kirkley M. et al. Expression of angiogenic growth factors by uterine natural killer cells during early pregnancy. J Leukoc Biol 2006; 80 (03) 572-580
    CrossrefPubMedGoogle Scholar
  • 29 Chakraborty D, Rumi MA, Konno T, Soares MJ. Natural killer cells direct hemochorial placentation by regulating hypoxia-inducible factor dependent trophoblast lineage decisions. Proc Natl Acad Sci U S A 2011; 108 (39) 16295-16300
    CrossrefPubMedGoogle Scholar
  • 30 Brighton PJ, Maruyama Y, Fishwick K. et al. Clearance of senescent decidual cells by uterine natural killer cells in cycling human endometrium. eLife 2017; 6: e31274
    CrossrefPubMedGoogle Scholar
  • 31 Tuckerman E, Mariee N, Prakash A, Li TC, Laird S. Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF. J Reprod Immunol 2010; 87 (1-2): 60-66
    CrossrefPubMedGoogle Scholar
  • 32 Santillán I, Lozano I, Illán J. et al. Where and when should natural killer cells be tested in women with repeated implantation failure?. J Reprod Immunol 2015; 108: 142-148
    CrossrefPubMedGoogle Scholar
  • 33 Laird SL, Lash GE, Li TC, Bulmer JN. The role of natural killer cells in human fertility. Scientific Impact Paper No 53. Royal College of Obstetricians and Gynaecologists; 2016
    Google Scholar
  • 34 Royal College of Obstetricians and Gynaecologist. The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green Top Guideline No. 17; 2011
    Google Scholar
  • 35 Bender Atik R, Christiansen OB, Elson J. et al; ESHRE Guideline Group on RPL. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open 2018; 2018 (02) hoy004
    Google Scholar
  • 36 Quenby S, Bates M, Doig T. et al. Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 1999; 14 (09) 2386-2391
    CrossrefPubMedGoogle Scholar
  • 37 Tuckerman E, Laird SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 22 (08) 2208-2213
    CrossrefPubMedGoogle Scholar
  • 38 Clifford K, Flanagan AM, Regan L. Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14 (11) 2727-2730
    CrossrefPubMedGoogle Scholar
  • 39 Michimata T, Ogasawara MS, Tsuda H. et al. Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 2002; 47 (04) 196-202
    CrossrefPubMedGoogle Scholar
  • 40 Shimada S, Kato EH, Morikawa M. et al. No difference in natural killer or natural killer T-cell population, but aberrant T-helper cell population in the endometrium of women with repeated miscarriage. Hum Reprod 2004; 19 (04) 1018-1024
    CrossrefPubMedGoogle Scholar
  • 41 Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 2014; 20 (03) 429-438
    CrossrefPubMedGoogle Scholar
  • 42 Tang AW, Alfirevic Z, Quenby S. Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011; 26 (08) 1971-1980
    CrossrefPubMedGoogle Scholar
  • 43 Sacks G, Yang Y, Gowen E, Smith S, Fay L, Chapman M. Detailed analysis of peripheral blood natural killer cells in women with repeated IVF failure. Am J Reprod Immunol 2012; 67 (05) 434-442
    CrossrefPubMedGoogle Scholar
  • 44 Thum MY, Bhaskaran S, Bansal AS. et al. Simple enumerations of peripheral blood natural killer (CD56+ NK) cells, B cells and T cells have no predictive value in IVF treatment outcome. Hum Reprod 2005; 20 (05) 1272-1276
    CrossrefPubMedGoogle Scholar
  • 45 Katano K, Suzuki S, Ozaki Y, Suzumori N, Kitaori T, Sugiura-Ogasawara M. Peripheral natural killer cell activity as a predictor of recurrent pregnancy loss: a large cohort study. Fertil Steril 2013; 100 (06) 1629-1634
    CrossrefPubMedGoogle Scholar
  • 46 Alecsandru D, Garrido N, Vicario JL. et al. Maternal KIR haplotype influences live birth rate after double embryo transfer in IVF cycles in patients with recurrent miscarriages and implantation failure. Hum Reprod 2014; 29 (12) 2637-2643
    CrossrefPubMedGoogle Scholar
  • 47 Hiby SE, Regan L, Lo W, Farrell L, Carrington M, Moffett A. Association of maternal killer-cell immunoglobulin-like receptors and parental HLA-C genotypes with recurrent miscarriage. Hum Reprod 2008; 23 (04) 972-976
    CrossrefPubMedGoogle Scholar
  • 48 Varla-Leftherioti M, Spyropoulou-Vlachou M, Niokou D. et al. Natural killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions. Am J Reprod Immunol 2003; 49 (03) 183-191
    CrossrefPubMedGoogle Scholar
  • 49 Kuroda K, Venkatakrishnan R, James S. et al. Elevated periimplantation uterine natural killer cell density in human endometrium is associated with impaired corticosteroid signaling in decidualizing stromal cells. J Clin Endocrinol Metab 2013; 98 (11) 4429-4437
    CrossrefPubMedGoogle Scholar
  • 50 Quenby S, Kalumbi C, Bates M, Farquharson R, Vince G. Prednisolone reduces preconceptual endometrial natural killer cells in women with recurrent miscarriage. Fertil Steril 2005; 84 (04) 980-984
    CrossrefPubMedGoogle Scholar
  • 51 Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod 2013; 28 (07) 1743-1752
    CrossrefPubMedGoogle Scholar
  • 52 Alhalabi M, Alsamawi S, Taha A. et al. Prednisolone improves implantation in ICSI patients with high peripheral CD69+ NK cells. Hum Reprod 2011; 26 (01) i219
    PubMedGoogle Scholar
  • 53 Ubaldi F, Rienzi L, Ferrero S. et al. Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Hum Reprod 2002; 17 (06) 1544-1547
    CrossrefPubMedGoogle Scholar
  • 54 Boomsma CM, Keay SD, Macklon NS. Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database Syst Rev 2012; (06) CD005996
    PubMedGoogle Scholar
  • 55 Zhang T, Huang C, Du Y. et al. Successful treatment with intrauterine delivery of dexamethasone for repeated implantation failure. Am J Reprod Immunol 2017; 78 (06) DOI: 10.1111/aji.12766.
    CrossrefPubMedGoogle Scholar
  • 56 Moraru M, Carbone J, Alecsandru D. et al. Intravenous immunoglobulin treatment increased live birth rate in a Spanish cohort of women with recurrent reproductive failure and expanded CD56(+) cells. Am J Reprod Immunol 2012; 68 (01) 75-84
    CrossrefPubMedGoogle Scholar
  • 57 Nyborg KM, Kolte AM, Larsen EC, Christiansen OB. Immunomodulatory treatment with intravenous immunoglobulin and prednisone in patients with recurrent miscarriage and implantation failure after in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2014; 102 (06) 1650-5.e1
    CrossrefPubMedGoogle Scholar
  • 58 Wang S-W, Zhong S-Y, Lou L-J, Hu ZF, Sun HY, Zhu HY. The effect of intravenous immunoglobulin passive immunotherapy on unexplained recurrent spontaneous abortion: a meta-analysis. Reprod Biomed Online 2016; 33 (06) 720-736
    CrossrefPubMedGoogle Scholar
  • 59 Mekinian A, Cohen J, Alijotas-Reig J. et al. Unexplained recurrent miscarriage and recurrent implantation failure: Is there a place for immunomodulation?. Am J Reprod Immunol 2016; 76 (01) 8-28
    CrossrefPubMedGoogle Scholar
  • 60 Coulam CB, Acacio B. Does immunotherapy for treatment of reproductive failure enhance live births?. Am J Reprod Immunol 2012; 67 (04) 296-304
    CrossrefPubMedGoogle Scholar
  • 61 Roussev RG, Ng SC, Coulam CB. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G. Am J Reprod Immunol 2007; 57 (04) 262-269
    CrossrefPubMedGoogle Scholar
  • 62 Roussev RG, Acacio B, Ng SC, Coulam CB. Duration of intralipid's suppressive effect on NK cell's functional activity. Am J Reprod Immunol 2008; 60 (03) 258-263
    CrossrefPubMedGoogle Scholar
  • 63 Shirlow RH, Healey M, Volovsky M. et al. The effect of intralipid on pregnancy rates in in vitro fertilisation (IVF). Fertil Steril 2016; 106: e337-e338
    CrossrefPubMedGoogle Scholar
  • 64 Hartl WH, Jauch KW, Parhofer K, Rittler P. Working Group for Developing the Guidelines for Parenteral Nutrition of the German Association for Nutritional Medicine. Complications and monitoring - guidelines on parenteral nutrition, Chapter 11. Ger Med Sci 2009; 7: Doc17
    PubMedGoogle Scholar
  • 65 Lash GE, Bulmer JN, Li TC. et al. Standardisation of uterine natural killer (uNK) cell measurements in the endometrium of women with recurrent reproductive failure. J Reprod Immunol 2016; 116: 50-59
    CrossrefPubMedGoogle Scholar
  • 66 Chen X, Mariee N, Jiang L. et al. Measurement of uterine natural killer cell percentage in the periimplantation endometrium from fertile women and women with recurrent reproductive failure: establishment of a reference range. Am J Obstet Gynecol 2017; 217 (06) 680.e1-680.e6
    CrossrefPubMedGoogle Scholar
  • 67 Christiansen OB. Reproductive immunology. Mol Immunol 2013; 55 (01) 8-15
    CrossrefPubMedGoogle Scholar
  • 68 Kimura F, Takebayashi A, Ishida M. et al. Review: chronic endometritis and its effect on reproduction. J Obstet Gynaecol Res 2019; 45 (05) 951-960
    CrossrefPubMedGoogle Scholar
  • 69 Moreno I, Cicinelli E, Garcia-Grau I. et al. The diagnosis of chronic endometritis in infertile asymptomatic women: a comparative study of histology, microbial cultures, hysteroscopy, and molecular microbiology. Am J Obstet Gynecol 2018; 218 (06) 602.e1-602.e16
    CrossrefPubMedGoogle Scholar
  • 70 Moreno I, Codoñer FM, Vilella F. et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol 2016; 215 (06) 684-703
    CrossrefPubMedGoogle Scholar
  • 71 McQueen DB, Perfetto CO, Hazard FK, Lathi RB. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril 2015; 104 (04) 927-931
    CrossrefPubMedGoogle Scholar
  • 72 Cicinelli E, Resta L, Nicoletti R. et al. Detection of chronic endometritis at fluid hysteroscopy. J Minim Invasive Gynecol 2005; 12 (06) 514-518
    CrossrefPubMedGoogle Scholar
  • 73 Cicinelli E, De Ziegler D, Nicoletti R. et al. Chronic endometritis: correlation among hysteroscopic, histologic, and bacteriologic findings in a prospective trial with 2190 consecutive office hysteroscopies. Fertil Steril 2008; 89 (03) 677-684
    CrossrefPubMedGoogle Scholar
  • 74 Li Y, Yu S, Huang C. et al. Evaluation of peripheral and uterine immune status of chronic endometritis in patients with recurrent reproductive failure. Fertil Steril 2020; 113 (01) 187-196.e1
    CrossrefPubMedGoogle Scholar
  • 75 Aghaeepour N, Ganio EA, Mcilwain D. et al. An immune clock of human pregnancy. Sci Immunol 2017; 2 (15) eaan2946
    CrossrefPubMedGoogle Scholar
  • 76 Matteo M, Cicinelli E, Greco P. et al. Abnormal pattern of lymphocyte subpopulations in the endometrium of infertile women with chronic endometritis. Am J Reprod Immunol 2009; 61 (05) 322-329
    CrossrefPubMedGoogle Scholar
  • 77 Kitaya K, Yasuo T. Aberrant expression of selectin E, CXCL1, and CXCL13 in chronic endometritis. Mod Pathol 2010; 23 (08) 1136-1146
    CrossrefPubMedGoogle Scholar
  • 78 Wu D, Kimura F, Zheng L. et al. Chronic endometritis modifies decidualization in human endometrial stromal cells. Reprod Biol Endocrinol 2017; 15 (01) 16
    CrossrefPubMedGoogle Scholar
  • 79 Huang W, Liu B, He Y. et al. Variation of diagnostic criteria in women with chronic endometritis and its effect on reproductive outcomes: a systematic review and meta-analysis. J Reprod Immunol 2020; 140: 103146
    CrossrefPubMedGoogle Scholar
  • 80 Bouet P-E, El Hachem H, Monceau E, Gariépy G, Kadoch IJ, Sylvestre C. Chronic endometritis in women with recurrent pregnancy loss and recurrent implantation failure: prevalence and role of office hysteroscopy and immunohistochemistry in diagnosis. Fertil Steril 2016; 105 (01) 106-110
    CrossrefPubMedGoogle Scholar
  • 81 Liu Y, Chen X, Huang J. et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril 2018; 109 (05) 832-839
    CrossrefPubMedGoogle Scholar
  • 82 Cicinelli E, Matteo M, Tinelli R. et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci 2014; 21 (05) 640-647
    CrossrefPubMedGoogle Scholar
  • 83 Gkrozou F, Tsonis O, Dimitriou E, Paschopoulos M. In women with chronic or subclinical endometritis is hysteroscopy suitable for setting the diagnosis? A systematic review. J Obstet Gynaecol Res 2020; 46 (09) 1639-1650
    CrossrefPubMedGoogle Scholar
  • 84 Johnston-MacAnanny EB, Hartnett J, Engmann LL, Nulsen JC, Sanders MM, Benadiva CA. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 2010; 93 (02) 437-441
    CrossrefPubMedGoogle Scholar
  • 85 Cicinelli E, Matteo M, Tinelli R. et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy. Hum Reprod 2015; 30 (02) 323-330
    CrossrefPubMedGoogle Scholar
  • 86 Vitagliano A, Saccardi C, Noventa M. et al. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: a systematic review and meta-analysis. Fertil Steril 2018; 110 (01) 103-112.e1
    CrossrefPubMedGoogle Scholar
  • 87 Yang R, Du X, Wang Y, Song X, Yang Y, Qiao J. The hysteroscopy and histological diagnosis and treatment value of chronic endometritis in recurrent implantation failure patients. Arch Gynecol Obstet 2014; 289 (06) 1363-1369
    CrossrefPubMedGoogle Scholar
  • 88 ISRCTN Registry. The effect of doxycycline on live birth rates in women with chronic endometritis suffering from recurrent miscarriage. Accessed October 6, 2020 at: http://www.isrctn.com/ISRCTN23947730
    Google Scholar
  • 89 Ng SC, Gilman-Sachs A, Thaker P, Beaman KD, Beer AE, Kwak-Kim J. Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF/ET or normal pregnancy. Am J Reprod Immunol 2002; 48 (02) 77-86
    CrossrefPubMedGoogle Scholar
  • 90 Kwak-Kim JY, Chung-Bang HS, Ng SC. et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod 2003; 18 (04) 767-773
    CrossrefPubMedGoogle Scholar
  • 91 Nakagawa K, Kwak-Kim J, Ota K. et al. Immunosuppression with tacrolimus improved reproductive outcome of women with repeated implantation failure and elevated peripheral blood TH1/TH2 cell ratios. Am J Reprod Immunol 2015; 73 (04) 353-361
    CrossrefPubMedGoogle Scholar
  • 92 Lédée-Bataille N, Dubanchet S, Kadoch J. et al. Controlled natural in vitro fertilization may be an alternative for patients with repeated unexplained implantation failure and a high uterine natural killer cell count. Fertil Steril 2004; 82 (01) 234-236
    CrossrefPubMedGoogle Scholar
  • 93 Lachapelle MH, Miron P, Hemmings R, Roy DC. Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion: altered profile and pregnancy outcome. J Immunol 1996; 156 (10) 4027-4034
    CrossrefPubMedGoogle Scholar
  • 94 Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. Am J Reprod Immunol 2003; 50 (04) 351-354
    CrossrefPubMedGoogle Scholar
  • 95 Aoki K, Kajiura S, Matsumoto Y. et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995; 345 (8961): 1340-1342
    CrossrefPubMedGoogle Scholar
  • 96 Matsubayashi H, Shida M, Kondo A. et al. Preconception peripheral natural killer cell activity as a predictor of pregnancy outcome in patients with unexplained infertility. Am J Reprod Immunol 2005; 53 (03) 126-131
    CrossrefPubMedGoogle Scholar
  • 97 Kitaya K. Prevalence of chronic endometritis in recurrent miscarriages. Fertil Steril 2011; 95 (03) 1156-1158
    CrossrefPubMedGoogle Scholar